Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $148.87 million. The enterprise value is -$39.35 million.

Market Cap	148.87M
Enterprise Value	-39.35M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 65.29 million shares outstanding. The number of shares has increased by 199.50% in one year.

Current Share Class	65.29M
Shares Outstanding	65.29M
Shares Change (YoY)	+199.50%
Shares Change (QoQ)	+16.53%
Owned by Insiders (%)	5.56%
Owned by Institutions (%)	44.48%
Float	40.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.97
P/TBV Ratio	0.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.36

Current Ratio	10.36
Quick Ratio	10.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.85% and return on invested capital (ROIC) is -24.51%.

Return on Equity (ROE)	-36.85%
Return on Assets (ROA)	-21.40%
Return on Capital (ROIC)	-24.51%
Revenue Per Employee	n/a
Profits Per Employee	-$2.84M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.40% in the last 52 weeks. The beta is -0.03, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-54.40%
50-Day Moving Average	3.61
200-Day Moving Average	3.76
Relative Strength Index (RSI)	34.28
Average Volume (20 Days)	563,071

Short Selling Information

The latest short interest is 5.16 million, so 7.91% of the outstanding shares have been sold short.

Short Interest	5.16M
Short Previous Month	4.96M
Short % of Shares Out	7.91%
Short % of Float	12.63%
Short Ratio (days to cover)	5.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-50.28M
Pretax Income	-58.52M
Net Income	-42.62M
EBITDA	n/a
EBIT	-50.28M
Earnings Per Share (EPS)	-$0.66

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	188.22M
Total Debt	n/a
Net Cash	188.22M
Net Cash Per Share	$2.88
Equity (Book Value)	170.83M
Book Value Per Share	2.34
Working Capital	170.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.31 million and capital expenditures -$30,000, giving a free cash flow of -$21.34 million.

Operating Cash Flow	-21.31M
Capital Expenditures	-30,000
Free Cash Flow	-21.34M
FCF Per Share	-$0.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-199.50%
Shareholder Yield	-199.50%
Earnings Yield	-28.63%
FCF Yield	-14.33%

Analyst Forecast

The average price target for Zura Bio is $15.80, which is 592.98% higher than the current price. The consensus rating is "Buy".

Price Target	$15.80
Price Target Difference	592.98%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2